.png)
Retatrutide
A triple-agonist peptide studied in metabolic research for activity across GLP-1, GIP, and glucagon receptor pathways. One of the newest additions to the catalog, held to the same purity threshold as everything else we carry.
For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy.
What the research covers.
Retatrutide is studied as a multi-receptor agonist, with laboratory research focused on its combined activity across GLP-1, GIP, and glucagon pathways — a profile that distinguishes it from single-target GLP-1 research compounds.
Retatrutide is the first compound moving through independent Vanguard certification — purity, net content, and identity — with results published to the certificate library as soon as they're in. For Research Use Only. Not for Human Consumption. Not for use in diagnostic or therapeutic procedures. This product has not been evaluated by the FDA for safety or efficacy.
